Sodium oxybate 500 MG/ML Oral Solution [Xyrem] — RxCUI 352257
RxNorm drug concept · Semantic branded drug
RxCUI 352257
Semantic branded drug · SBD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI352257
Official nameSodium oxybate 500 MG/ML Oral Solution [Xyrem]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXyrem 0.5 GM per 1 ML Oral Solution; XYREM 0.5 GM in 1 mL Oral Solution; Xyrem 500 MG per 1 ML Oral Solution
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)1,331 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sodium Oxybate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's a great question, and the answer depends on which product you're prescribed. If you're on Xyrem or the generic oral solution, yes — you do need two doses spaced about 2.5 to...
- Why do I have to take two doses in the middle of the night — can't I just take it all at once?
- No — alcohol and sodium oxybate absolutely cannot be mixed, even if there are hours between them. Combining the two dramatically increases the risk of your breathing slowing down d...
- Can I have a glass of wine with dinner if I take my dose hours later at bedtime?
🕸️ Concept Web — How Sodium oxybate 500 MG/ML Oral Solution [Xyrem] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sodium oxybate 500 MG/ML Oral Solution [Xyrem]
RxCUI 352257 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Oxybate
2387302IN -
Sodium oxybate
9899PIN
-
Oxybate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xyrem
353098BN
-
Xyrem
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Oxybate Oral Solution
378683SCDF -
Sodium oxybate Oral Solution
2645979SCDFP -
Oxybate Oral Liquid Product
2392730SCDG -
Oxybate Oral Product
2392731SCDG -
Sodium oxybate Oral Liquid Product
2662477SCDGP -
Sodium oxybate Oral Product
2660169SCDGP -
Oxybate Oral Solution [Xyrem]
364389SBDF -
Sodium oxybate Oral Solution [Xyrem]
2655721SBDFP - +5 more in this family
-
Oxybate Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sodium oxybate 500 MG/ML Oral Solution
349482SCD -
Sodium oxybate 500 MG/ML
351020SCDC -
Sodium oxybate 500 MG/ML [Xyrem]
575962SBDC
-
Sodium oxybate 500 MG/ML Oral Solution
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sodium oxybate 500 MG/ML Oral Solution
SCD · 349482 -
Sodium oxybate 500 MG/ML
SCDC · 351020 -
Oxybate Oral Solution
SCDF · 378683 -
Sodium oxybate Oral Solution
SCDFP · 2645979 -
Oxybate Oral Liquid Product
SCDG · 2392730 -
Oxybate Oral Product
SCDG · 2392731 -
Sodium oxybate Oral Liquid Product
SCDGP · 2662477 -
Sodium oxybate Oral Product
SCDGP · 2660169
Brand-Name Concepts
-
Sodium oxybate 500 MG/ML [Xyrem]
SBDC · 575962 -
Oxybate Oral Solution [Xyrem]
SBDF · 364389 -
Sodium oxybate Oral Solution [Xyrem]
SBDFP · 2655721 -
Xyrem Oral Liquid Product
SBDG · 1186634 -
Xyrem Oral Product
SBDG · 1186635 -
Xyrem
BN · 353098
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 352257 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 68727-0100-01 | 180 mL in 1 BOTTLE, PLASTIC (68727-100-01) | Xyrem | Jazz Pharmaceuticals, Inc. | 2002-07-17 |
Observed labelers:
Jazz Pharmaceuticals, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.